JOHANNESBURG (Reuters) – South Africa’s MTN Group (MTNJ.J) has signed an expanded roaming and services agreement with the country’s third-biggest carrier Cell C, MTN said on Monday, pushing shares in rival Telkom (TKGJ.J) down more than 5%. The deal puts a dam... More »
Israel’s Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants. More »
Israel’s BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS), a neuro-degenerative disease, even before it completes late-stage clinical trials. More »
Cellectis has won U.S. regulatory approval to run an early clinical trial using its gene edited cell therapy product UCART123 for blood cancers, boosting the French biotech firm’s ambitions in the hot area of cancer research. More »
WASHINGTON Scientists on Thursday announced the creation of a synthetic organism stripped down to the bare essentials with the fewest genes needed to survive and multiply, a feat at the microscopic level that may provide big insights on the very nature of life... More »
